Pulse Biosciences (PLSE) Depreciation & Amortization (CF) (2015 - 2025)

Pulse Biosciences' Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $100000.0 for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 17.36% year-over-year to $100000.0; the TTM figure through Dec 2025 stood at $400000.0 (down 4.99% YoY), while the FY2025 annual figure was $400000.0, down 21.88% from the prior year.
• Depreciation & Amortization (CF) was $100000.0 for Q4 2025 at Pulse Biosciences, roughly flat from $100000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $200000.0 in Q4 2021 to a low of $100000.0 in Q1 2021.
• Historically, Depreciation & Amortization (CF) has averaged $117550.0 across 5 years, with a median of $100000.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) surged 100.0% in 2022, then sank 50.0% in 2023.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $200000.0 in 2021, then retreated by 15.0% to $170000.0 in 2022, then slumped by 41.18% to $100000.0 in 2023, then increased by 21.0% to $121000.0 in 2024, then declined by 17.36% to $100000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $100000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q2 2025), per Business Quant data.